Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer
Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of...
Ausführliche Beschreibung
Autor*in: |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
1982 |
---|
Umfang: |
6 |
---|
Reproduktion: |
Springer Online Journal Archives 1860-2002 |
---|---|
Übergeordnetes Werk: |
in: Urological research - 1973, 10(1982) vom: Feb., Seite 75-80 |
Übergeordnetes Werk: |
volume:10 ; year:1982 ; month:02 ; pages:75-80 ; extent:6 |
Links: |
---|
Katalog-ID: |
NLEJ202594262 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ202594262 | ||
003 | DE-627 | ||
005 | 20210706103533.0 | ||
007 | cr uuu---uuuuu | ||
008 | 070528s1982 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)NLEJ202594262 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer |
264 | 1 | |c 1982 | |
300 | |a 6 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. | ||
533 | |f Springer Online Journal Archives 1860-2002 | ||
700 | 1 | |a Huber, P. R. |4 oth | |
700 | 1 | |a Zaugg, Th. |4 oth | |
700 | 1 | |a Linder, E. |4 oth | |
700 | 1 | |a Hagmaier, V. |4 oth | |
700 | 1 | |a Rutishauser, G. |4 oth | |
773 | 0 | 8 | |i in |t Urological research |d 1973 |g 10(1982) vom: Feb., Seite 75-80 |w (DE-627)NLEJ188993312 |w (DE-600)1461962-3 |x 1434-0879 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:1982 |g month:02 |g pages:75-80 |g extent:6 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/BF00262406 |
912 | |a GBV_USEFLAG_U | ||
912 | |a ZDB-1-SOJ | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 10 |j 1982 |c 2 |h 75-80 |g 6 |
matchkey_str |
article:14340879:1982----::raieiaesezmcbicmiainorsaiaipopaaeesrdyii |
---|---|
hierarchy_sort_str |
1982 |
publishDate |
1982 |
allfields |
(DE-627)NLEJ202594262 DE-627 ger DE-627 rakwb eng Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer 1982 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. Springer Online Journal Archives 1860-2002 Huber, P. R. oth Zaugg, Th. oth Linder, E. oth Hagmaier, V. oth Rutishauser, G. oth in Urological research 1973 10(1982) vom: Feb., Seite 75-80 (DE-627)NLEJ188993312 (DE-600)1461962-3 1434-0879 nnns volume:10 year:1982 month:02 pages:75-80 extent:6 http://dx.doi.org/10.1007/BF00262406 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 10 1982 2 75-80 6 |
spelling |
(DE-627)NLEJ202594262 DE-627 ger DE-627 rakwb eng Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer 1982 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. Springer Online Journal Archives 1860-2002 Huber, P. R. oth Zaugg, Th. oth Linder, E. oth Hagmaier, V. oth Rutishauser, G. oth in Urological research 1973 10(1982) vom: Feb., Seite 75-80 (DE-627)NLEJ188993312 (DE-600)1461962-3 1434-0879 nnns volume:10 year:1982 month:02 pages:75-80 extent:6 http://dx.doi.org/10.1007/BF00262406 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 10 1982 2 75-80 6 |
allfields_unstemmed |
(DE-627)NLEJ202594262 DE-627 ger DE-627 rakwb eng Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer 1982 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. Springer Online Journal Archives 1860-2002 Huber, P. R. oth Zaugg, Th. oth Linder, E. oth Hagmaier, V. oth Rutishauser, G. oth in Urological research 1973 10(1982) vom: Feb., Seite 75-80 (DE-627)NLEJ188993312 (DE-600)1461962-3 1434-0879 nnns volume:10 year:1982 month:02 pages:75-80 extent:6 http://dx.doi.org/10.1007/BF00262406 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 10 1982 2 75-80 6 |
allfieldsGer |
(DE-627)NLEJ202594262 DE-627 ger DE-627 rakwb eng Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer 1982 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. Springer Online Journal Archives 1860-2002 Huber, P. R. oth Zaugg, Th. oth Linder, E. oth Hagmaier, V. oth Rutishauser, G. oth in Urological research 1973 10(1982) vom: Feb., Seite 75-80 (DE-627)NLEJ188993312 (DE-600)1461962-3 1434-0879 nnns volume:10 year:1982 month:02 pages:75-80 extent:6 http://dx.doi.org/10.1007/BF00262406 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 10 1982 2 75-80 6 |
allfieldsSound |
(DE-627)NLEJ202594262 DE-627 ger DE-627 rakwb eng Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer 1982 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. Springer Online Journal Archives 1860-2002 Huber, P. R. oth Zaugg, Th. oth Linder, E. oth Hagmaier, V. oth Rutishauser, G. oth in Urological research 1973 10(1982) vom: Feb., Seite 75-80 (DE-627)NLEJ188993312 (DE-600)1461962-3 1434-0879 nnns volume:10 year:1982 month:02 pages:75-80 extent:6 http://dx.doi.org/10.1007/BF00262406 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 10 1982 2 75-80 6 |
language |
English |
source |
in Urological research 10(1982) vom: Feb., Seite 75-80 volume:10 year:1982 month:02 pages:75-80 extent:6 |
sourceStr |
in Urological research 10(1982) vom: Feb., Seite 75-80 volume:10 year:1982 month:02 pages:75-80 extent:6 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
isfreeaccess_bool |
false |
container_title |
Urological research |
authorswithroles_txt_mv |
Huber, P. R. @@oth@@ Zaugg, Th. @@oth@@ Linder, E. @@oth@@ Hagmaier, V. @@oth@@ Rutishauser, G. @@oth@@ |
publishDateDaySort_date |
1982-02-01T00:00:00Z |
hierarchy_top_id |
NLEJ188993312 |
id |
NLEJ202594262 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ202594262</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706103533.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1982 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ202594262</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huber, P. R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zaugg, Th.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Linder, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hagmaier, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rutishauser, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Urological research</subfield><subfield code="d">1973</subfield><subfield code="g">10(1982) vom: Feb., Seite 75-80</subfield><subfield code="w">(DE-627)NLEJ188993312</subfield><subfield code="w">(DE-600)1461962-3</subfield><subfield code="x">1434-0879</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:1982</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:75-80</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF00262406</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">1982</subfield><subfield code="c">2</subfield><subfield code="h">75-80</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
series2 |
Springer Online Journal Archives 1860-2002 |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ188993312 |
format |
electronic Article |
delete_txt_mv |
keep |
collection |
NL |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1434-0879 |
topic_title |
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
p r h pr prh t z tz e l el v h vh g r gr |
hierarchy_parent_title |
Urological research |
hierarchy_parent_id |
NLEJ188993312 |
hierarchy_top_title |
Urological research |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ188993312 (DE-600)1461962-3 |
title |
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer |
spellingShingle |
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer |
ctrlnum |
(DE-627)NLEJ202594262 |
title_full |
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer |
journal |
Urological research |
journalStr |
Urological research |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
1982 |
contenttype_str_mv |
zzz |
container_start_page |
75 |
container_volume |
10 |
physical |
6 |
format_se |
Elektronische Aufsätze |
title_sort |
creatine kinase isoenzyme (ck-bb) in combination to prostatic acid phosphatase measured by ria in the diagnosis of prostatic cancer |
title_auth |
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer |
abstract |
Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. |
abstractGer |
Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. |
abstract_unstemmed |
Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate. |
collection_details |
GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE |
title_short |
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer |
url |
http://dx.doi.org/10.1007/BF00262406 |
remote_bool |
true |
author2 |
Huber, P. R. Zaugg, Th Linder, E. Hagmaier, V. Rutishauser, G. |
author2Str |
Huber, P. R. Zaugg, Th Linder, E. Hagmaier, V. Rutishauser, G. |
ppnlink |
NLEJ188993312 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth |
up_date |
2024-07-06T08:20:20.279Z |
_version_ |
1803817079570169856 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ202594262</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706103533.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1982 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ202594262</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1982</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary Creatine kinase isoenzyme (CK-BB) measured by mass was used to determine its value in the early diagnosis of prostatic cancer. Sera of patients with prostatic carcinoma of various stages (treated and untreated) were compared to normal male sera and sera of patients with benign hyperplasia of the prostate (BPH) with respect to CK-BB. The sera were simultaneously tested for PAP content. The sensitivity of the CK-BB-RIA was 1.63+/-0.08 μg/l and reproducibility in the higher and lower concentration range 7.6% and 10.5%, respectively. CK-BB alone or in combination with PAP is no marker for early detection of prostatic cancer. In individual cases changes occurred similar to those found with a malignant growth of the prostate.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huber, P. R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zaugg, Th.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Linder, E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hagmaier, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rutishauser, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Urological research</subfield><subfield code="d">1973</subfield><subfield code="g">10(1982) vom: Feb., Seite 75-80</subfield><subfield code="w">(DE-627)NLEJ188993312</subfield><subfield code="w">(DE-600)1461962-3</subfield><subfield code="x">1434-0879</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:1982</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:75-80</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF00262406</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">1982</subfield><subfield code="c">2</subfield><subfield code="h">75-80</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
score |
7.399747 |